Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
28 hedge funds and large institutions have $38.4M invested in Allergan Inc in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 7 closing their positions.
140% more capital invested
Capital invested by funds: $16M → $38.4M (+$22.4M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
4% more funds holding
Funds holding: 27 → 28 (+1)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
Top Sellers
AGN Hedge Fund Activity: Q4 2015 in Review
28 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q4 2015, worth a combined $38.4M — up 140% from $16M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AGN positions and 7 closed out — a net gain of 1 holder — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Summitry LLC, opening a new position worth an estimated $20.4M. The largest seller was Peregrine Asset Advisers, cutting an estimated $3M.
- 28 institutional investors held Allergan Inc (AGN) as of Q4 2015, up from 27 in Q3 2015.
- Funds reported $38.4M of Allergan Inc stock for Q4 2015, up 140% quarter-over-quarter.
- 8 funds opened new Allergan Inc positions in Q4 2015 and 7 closed out, a net change of +1 holder.
- The largest Allergan Inc buyer in Q4 2015 was Summitry LLC, an estimated $20.4M added.
- The largest Allergan Inc seller in Q4 2015 was Peregrine Asset Advisers, an estimated $3M sold.
Based on aggregated 13F filings for Q4 2015.